Your English writing platform
Discover LudwigSuggestions(2)
Exact(2)
No significant differences in attrition were observed in the first 3 months of treatment compared to later in therapy.
Similar patterns of attrition were observed across the study cohorts, with censoring of between 54-59 % of subjects in the duloxetine, venlafaxine, and SSRI cohorts within the first 8 weeks following initiation of the study drugs and 47%% of subjects in the untreated cohort within the same time frame.
Similar(58)
When the sodium benzoate (Purox-S) granules are attrition tested, significant attrition is observed.
Relatively fast rates of telomere attrition are observed during childhood and adolescence.
High rates of attrition are observed when cells exit the microvasculature into the parenchyma of tissue.
A similar attrition was observed in our pilot study [ 25] and several others [ 20, 45].
Of the remaining population, attrition was observed among 6.8%, with 2.9% documented to have died and 3.9% lost to follow-up [Table 2].
We are aware that a lengthy intervention may result in an attrition rate of about 25%, so we are expecting a drop to 0.82 in the study' power, if this attrition is observed.
However, participant characteristics as of the end of 2012 were similar overall to those reported by the Japanese government 44 47 (data not shown), and only minor attrition was observed (45/3425 over the course of about a year).
In agreement with recently published data by Novartis, 17 a high level of attrition was observed between the selected BCG compound set (777 compounds, Supporting Information) and the final H37Rv list (177 compounds, Supporting Information).
The highest attrition rates were observed among those who were already on ART at the time of presentation to the clinic.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com